Specialties
Elbow
Specialties
Hip
Specialties
Orthopaedics
129 results found in 3ms
Finding a ChondroFiller specialist in the UKFinding a ChondroFiller specialist in the UK
ChondroFillerinjectionfor focal cartilage defects requires real-time ultrasound guidance during placement. Most UK clinics lack this capability, so trained specialists concentrate in London.ChondroFiller injection for focal cartilage defects requires real-time ultrasound guidance during placement. Most UK clinics lack this capability, so trained specialists concentrate in London.
Which specialty treats spinal stenosis in the UKWhich specialty treats spinal stenosis in the UK
Most UK patients with spinal stenosis are managed by their GP and physiotherapist and never need surgery; for others, the pathway—physiotherapy, pain medicine, surgery—is determined by symptom severity and treatment response, not specialty ownership.Most UK patients with spinal stenosis are managed by their GP and physiotherapist and never need surgery; for others, the pathway—physiotherapy, pain medicine, surgery—is determined by symptom severity and treatment response, not specialty ownership.
ChondroFiller vs hyaluronic acid for knee cartilageChondroFiller vs hyaluronic acid for knee cartilage
ChondroFiller and hyaluronic acid solve different cartilage problems entirely: one is a collagen scaffold filling focal defects via cell recruitment; the other replenishes synovial lubricant for diffuse osteoarthritis. Patient imaging determines which is appropriate.ChondroFiller and hyaluronic acid solve different cartilage problems entirely: one is a collagen scaffold filling focal defects via cell recruitment; the other replenishes synovial lubricant for diffuse osteoarthritis. Patient imaging determines which is appropriate.
ChondroFiller repeat injections and long-term repairChondroFiller repeat injections and long-term repair
ChondroFiller recruits the patient's progenitor cells into a collagen scaffold that degrades over 12–18 months whilst repair tissue develops; 81% of hip patients achieved good or excellent outcomes at three to five years, but success depends heavily on whether osteoarthritis is early-stage or advanced.ChondroFiller recruits the patient's progenitor cells into a collagen scaffold that degrades over 12–18 months whilst repair tissue develops; 81% of hip patients achieved good or excellent outcomes at three to five years, but success depends heavily on whether osteoarthritis is early-stage or advanced.
129 results found in 3ms